Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-6-13
|
pubmed:abstractText |
IL-2R serum concentrations were assayed by a sandwich enzyme immunoassay method in order to ascertain if the measurement of the soluble form of IL-2R can be considered a useful marker of allograft rejection in heart and kidney transplanted patients. Serum IL-2R levels increased significantly compared to pre-operated values (1129 +/- 215 U/ml vs. 592 +/- 209 U/ml, p less than 0.01) in six heart-transplanted patients during acute rejection crises documented by clinical findings and endomyocardial biopsy, and returned to baseline levels after successful treatment (544 +/- 395 U/ml vs. 1129 +/- 215 U/ml, p less than 0.01). Moreover, we observed that severe bacterial (n = 5) or viral (n = 2) infections were also accompanied by a significant increase of IL-2R serum levels in heart-transplanted patients (1076 +/- 263 U/ml vs. 486 +/- 146 U/ml, p less than 0.01 in bacterial, and 1290 +/- 368 U/ml vs. 370 +/- 85 U/ml in viral infections). In the six patients with renal transplant, the mean pre-operative IL-2R level was also elevated (1507 +/- 203 U/ml). A 1.5-4 fold increase of IL-2R levels has been observed at the beginning of both acute rejection and clinically evident infection. Our data show that the serum concentration of IL-2R is increased in heart and kidney transplanted patients during allograft rejection crisis. However, the information gained with this assay must be cautiously interpreted because an increase of IL-2R concentrations can also indicate bacterial or viral infections.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-0868
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
261-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2699610-Adult,
pubmed-meshheading:2699610-Aged,
pubmed-meshheading:2699610-Biological Markers,
pubmed-meshheading:2699610-Cardiac Output, Low,
pubmed-meshheading:2699610-Female,
pubmed-meshheading:2699610-Graft Rejection,
pubmed-meshheading:2699610-Heart Transplantation,
pubmed-meshheading:2699610-Humans,
pubmed-meshheading:2699610-Immunoenzyme Techniques,
pubmed-meshheading:2699610-Kidney Diseases,
pubmed-meshheading:2699610-Kidney Transplantation,
pubmed-meshheading:2699610-Male,
pubmed-meshheading:2699610-Middle Aged,
pubmed-meshheading:2699610-Receptors, Interleukin-2
|
pubmed:year |
1989
|
pubmed:articleTitle |
Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patients.
|
pubmed:affiliation |
C.N.R. Institute of Clinical Physiology, University of Pisa, Italy.
|
pubmed:publicationType |
Journal Article
|